{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:38:31Z","timestamp":1777941511794,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1245\/s10434-020-08632-1","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T16:06:12Z","timestamp":1591113972000},"page":"3585-3592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1\u2013T2cN0 Patients with Positive Sentinel Nodes"],"prefix":"10.1245","volume":"27","author":[{"given":"Anita","family":"Mamtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"10","key":"8632_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918-926.","journal-title":"JAMA"},{"issue":"12","key":"8632_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u20131310.","journal-title":"Lancet Oncol."},{"issue":"9","key":"8632_CR3","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1245\/s10434-014-3752-0","volume":"21","author":"J Gooch","year":"2014","unstructured":"Gooch J, King TA, Eaton A, et al. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1\u2013T2 breast cancer. Ann Surg Oncol. 2014;21(9):2897\u20132903.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"8632_CR4","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","volume":"27","author":"AV Barrio","year":"2020","unstructured":"Barrio AV, Downs-Canner S, Edelweiss M, et al. Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients. Ann Surg Oncol. 2020;27(5):1617\u201324.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"8632_CR5","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","volume":"10","author":"KJ Van Zee","year":"2003","unstructured":"Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140\u201351.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"8632_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/SLA.0b013e318238f461","volume":"255","author":"EA Mittendorf","year":"2012","unstructured":"Mittendorf EA, Hunt KK, Boughey JC, et al. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg. 2012;255(1):109\u201315.","journal-title":"Ann Surg."},{"issue":"4","key":"8632_CR7","first-page":"1063","volume":"25","author":"Y Kwon","year":"2011","unstructured":"Kwon Y, Ro J, Kang HS, et al. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients. Oncol Rep. 2011;25(4):1063\u201371.","journal-title":"Oncol Rep."},{"issue":"13","key":"8632_CR8","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","volume":"26","author":"A Katz","year":"2008","unstructured":"Katz A, Smith BL, Golshan M, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008;26(13):2093\u20138.","journal-title":"J Clin Oncol."},{"issue":"4","key":"8632_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0002-9610(01)00719-X","volume":"182","author":"SF Abdessalam","year":"2001","unstructured":"Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg. 2001;182(4):316\u201320.","journal-title":"Am J Surg."},{"key":"8632_CR10","doi-asserted-by":"crossref","unstructured":"van la Parra RF, Peer PG, de Roos WK, Ernst MF, de Wilt JH, Bosscha K. A simple risk score to predict the presence of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node. World J Surg. 2014;38(5):1070\u20136.","DOI":"10.1007\/s00268-013-2387-9"},{"issue":"4","key":"8632_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijrobp.2008.12.028","volume":"75","author":"B Unal","year":"2009","unstructured":"Unal B, Gur AS, Beriwal S, et al. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys. 2009;75(4):1035\u201340.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"8632_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1054\/brst.2000.0233","volume":"10","author":"JA Bucci","year":"2001","unstructured":"Bucci JA, Kennedy CW, Burn J, et al. Implications of extranodal spread in node positive breast cancer: a review of survival and local recurrence. Breast. 2001;10(3):213\u20139.","journal-title":"Breast"},{"issue":"4","key":"8632_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5152\/ejbh.2018.4038","volume":"14","author":"G Kanyilmaz","year":"2018","unstructured":"Kanyilmaz G, Findik S, Yavuz BB, Aktan M. The significance of extent of extracapsular extension in patients with T1-2 and N1 breast cancer. Eur J Breast Health. 2018;14(4):218\u201324.","journal-title":"Eur J Breast Health."},{"issue":"7","key":"8632_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jso.20758","volume":"95","author":"H Altinyollar","year":"2007","unstructured":"Altinyollar H, Berberoglu U, Gulben K, Irkin F. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer. J Surg Oncol. 2007;95(7):567\u201371.","journal-title":"J Surg Oncol."},{"issue":"10","key":"8632_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3816\/CBC.2007.n.042","volume":"7","author":"S Gorgulu","year":"2007","unstructured":"Gorgulu S, Can MF, Yagci G, Sahin M, Tufan T. Extracapsular extension is associated with increased ratio of metastatic to examined lymph nodes in axillary node-positive breast cancer. Clin Breast Cancer. 2007;7(10):796\u2013800.","journal-title":"Clin Breast Cancer."},{"issue":"3","key":"8632_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10549-013-2468-3","volume":"138","author":"TJ Meretoja","year":"2013","unstructured":"Meretoja TJ, Audisio RA, Heikkila PS, et al. International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases. Breast Cancer Res Treat. 2013;138(3):817\u201327.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"8632_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10549-018-05074-y","volume":"174","author":"MLG Vane","year":"2019","unstructured":"Vane MLG, Willemsen MA, van Roozendaal LM, et al. Extracapsular extension in the positive sentinel lymph node: a marker of poor prognosis in cT1\u20132N0 breast cancer patients? Breast Cancer Res Treat. 2019;174(3):711\u20138.","journal-title":"Breast Cancer Res Treat."},{"key":"8632_CR18","doi-asserted-by":"crossref","unstructured":"Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426\u201332 (discussion 432\u2013423).","DOI":"10.1097\/SLA.0b013e3181f08f32"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08632-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T23:32:16Z","timestamp":1622590336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08632-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["8632"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08632-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"11 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The preparation of this study was supported in part by NIH\/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center. Dr. Monica Morrow has received honoraria from Genomic Health; Dr. Andrea V. Barrio has received honoraria from Roche; and Debra Goldman owns stock in Johnson & Johnson unrelated to the study presented here. Anita Mamtani, Hannah Y. Wen, and Alain Vincent have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}